Global and United States Recombinant Vaccines Market Insights, Forecast to 2027

Global and United States Recombinant Vaccines Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Recombinant Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Vaccines Market Size Growth Rate by Type
1.2.2 Subunit Recombinant Vaccines
1.2.3 Attenuated Recombinant Vaccines
1.2.4 Vector Recombinant Vaccines
1.3 Market by Application
1.3.1 Global Recombinant Vaccines Market Size Growth Rate by Application
1.3.2 Recombinant Human Vaccines
1.3.3 Animal Recombinant Vaccines
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Recombinant Vaccines Revenue 2016-2027
2.1.2 Global Recombinant Vaccines Sales 2016-2027
2.2 Global Recombinant Vaccines, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Recombinant Vaccines Historical Market Size by Region (2016-2021)
2.3.1 Global Recombinant Vaccines Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Recombinant Vaccines Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Recombinant Vaccines Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Recombinant Vaccines Sales Forecast by Region (2022-2027)
2.4.2 Global Recombinant Vaccines Revenue Forecast by Region (2022-2027)
3 Global Recombinant Vaccines Competitor Landscape by Players
3.1 Global Top Recombinant Vaccines Manufacturers by Sales
3.1.1 Global Recombinant Vaccines Sales by Manufacturer (2016-2021)
3.1.2 Global Recombinant Vaccines Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Recombinant Vaccines Manufacturers by Revenue
3.2.1 Key Recombinant Vaccines Manufacturers Covered: Ranking by Revenue
3.2.2 Global Recombinant Vaccines Revenue by Manufacturers (2016-2021)
3.2.3 Global Recombinant Vaccines Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Recombinant Vaccines Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Recombinant Vaccines Revenue in 2020
3.2.6 Global Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Recombinant Vaccines Price by Manufacturers
3.4 Global Recombinant Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Recombinant Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Recombinant Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Recombinant Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Recombinant Vaccines Market Size by Type (2016-2021)
4.1.1 Global Recombinant Vaccines Sales by Type (2016-2021)
4.1.2 Global Recombinant Vaccines Revenue by Type (2016-2021)
4.1.3 Recombinant Vaccines Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Recombinant Vaccines Market Size Forecast by Type (2022-2027)
4.2.1 Global Recombinant Vaccines Sales Forecast by Type (2022-2027)
4.2.2 Global Recombinant Vaccines Revenue Forecast by Type (2022-2027)
4.2.3 Recombinant Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Recombinant Vaccines Market Size by Application (2016-2021)
5.1.1 Global Recombinant Vaccines Sales by Application (2016-2021)
5.1.2 Global Recombinant Vaccines Revenue by Application (2016-2021)
5.1.3 Recombinant Vaccines Price by Application (2016-2021)
5.2 Recombinant Vaccines Market Size Forecast by Application (2022-2027)
5.2.1 Global Recombinant Vaccines Sales Forecast by Application (2022-2027)
5.2.2 Global Recombinant Vaccines Revenue Forecast by Application (2022-2027)
5.2.3 Global Recombinant Vaccines Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Recombinant Vaccines Market Size YoY Growth 2016-2027
6.1.1 United States Recombinant Vaccines Sales YoY Growth 2016-2027
6.1.2 United States Recombinant Vaccines Revenue YoY Growth 2016-2027
6.1.3 United States Recombinant Vaccines Market Share in Global Market 2016-2027
6.2 United States Recombinant Vaccines Market Size by Players (International and Local Players)
6.2.1 United States Top Recombinant Vaccines Players by Sales (2016-2021)
6.2.2 United States Top Recombinant Vaccines Players by Revenue (2016-2021)
6.3 United States Recombinant Vaccines Historic Market Review by Type (2016-2021)
6.3.1 United States Recombinant Vaccines Sales Market Share by Type (2016-2021)
6.3.2 United States Recombinant Vaccines Revenue Market Share by Type (2016-2021)
6.3.3 United States Recombinant Vaccines Price by Type (2016-2021)
6.4 United States Recombinant Vaccines Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Recombinant Vaccines Sales Forecast by Type (2022-2027)
6.4.2 United States Recombinant Vaccines Revenue Forecast by Type (2022-2027)
6.4.3 United States Recombinant Vaccines Price Forecast by Type (2022-2027)
6.5 United States Recombinant Vaccines Historic Market Review by Application (2016-2021)
6.5.1 United States Recombinant Vaccines Sales Market Share by Application (2016-2021)
6.5.2 United States Recombinant Vaccines Revenue Market Share by Application (2016-2021)
6.5.3 United States Recombinant Vaccines Price by Application (2016-2021)
6.6 United States Recombinant Vaccines Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Recombinant Vaccines Sales Forecast by Application (2022-2027)
6.6.2 United States Recombinant Vaccines Revenue Forecast by Application (2022-2027)
6.6.3 United States Recombinant Vaccines Price Forecast by Application (2022-2027)
7 North America
7.1 North America Recombinant Vaccines Market Size YoY Growth 2016-2027
7.2 North America Recombinant Vaccines Market Facts & Figures by Country
7.2.1 North America Recombinant Vaccines Sales by Country (2016-2021)
7.2.2 North America Recombinant Vaccines Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Recombinant Vaccines Market Size YoY Growth 2016-2027
8.2 Asia Pacific Recombinant Vaccines Market Facts & Figures by Region
8.2.1 Asia Pacific Recombinant Vaccines Sales by Region (2016-2021)
8.2.2 Asia Pacific Recombinant Vaccines Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Recombinant Vaccines Market Size YoY Growth 2016-2027
9.2 Europe Recombinant Vaccines Market Facts & Figures by Country
9.2.1 Europe Recombinant Vaccines Sales by Country (2016-2021)
9.2.2 Europe Recombinant Vaccines Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Recombinant Vaccines Market Size YoY Growth 2016-2027
10.2 Latin America Recombinant Vaccines Market Facts & Figures by Country
10.2.1 Latin America Recombinant Vaccines Sales by Country (2016-2021)
10.2.2 Latin America Recombinant Vaccines Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Recombinant Vaccines Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Recombinant Vaccines Market Facts & Figures by Country
11.2.1 Middle East and Africa Recombinant Vaccines Sales by Country (2016-2021)
11.2.2 Middle East and Africa Recombinant Vaccines Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck & Co., Inc
12.1.1 Merck & Co., Inc Corporation Information
12.1.2 Merck & Co., Inc Description and Business Overview
12.1.3 Merck & Co., Inc Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck & Co., Inc Recombinant Vaccines Products Offered
12.1.5 Merck & Co., Inc Recent Development
12.2 Green Cross Corporation
12.2.1 Green Cross Corporation Corporation Information
12.2.2 Green Cross Corporation Description and Business Overview
12.2.3 Green Cross Corporation Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Green Cross Corporation Recombinant Vaccines Products Offered
12.2.5 Green Cross Corporation Recent Development
12.3 Pfizer Inc.
12.3.1 Pfizer Inc. Corporation Information
12.3.2 Pfizer Inc. Description and Business Overview
12.3.3 Pfizer Inc. Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Pfizer Inc. Recombinant Vaccines Products Offered
12.3.5 Pfizer Inc. Recent Development
12.4 Bayer AG
12.4.1 Bayer AG Corporation Information
12.4.2 Bayer AG Description and Business Overview
12.4.3 Bayer AG Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Bayer AG Recombinant Vaccines Products Offered
12.4.5 Bayer AG Recent Development
12.5 Sanofi S A.
12.5.1 Sanofi S A. Corporation Information
12.5.2 Sanofi S A. Description and Business Overview
12.5.3 Sanofi S A. Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sanofi S A. Recombinant Vaccines Products Offered
12.5.5 Sanofi S A. Recent Development
12.6 Protein Science Corporation
12.6.1 Protein Science Corporation Corporation Information
12.6.2 Protein Science Corporation Description and Business Overview
12.6.3 Protein Science Corporation Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Protein Science Corporation Recombinant Vaccines Products Offered
12.6.5 Protein Science Corporation Recent Development
12.7 GlaxoSmithKline Plc.
12.7.1 GlaxoSmithKline Plc. Corporation Information
12.7.2 GlaxoSmithKline Plc. Description and Business Overview
12.7.3 GlaxoSmithKline Plc. Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.7.4 GlaxoSmithKline Plc. Recombinant Vaccines Products Offered
12.7.5 GlaxoSmithKline Plc. Recent Development
12.8 Novartis AG
12.8.1 Novartis AG Corporation Information
12.8.2 Novartis AG Description and Business Overview
12.8.3 Novartis AG Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Novartis AG Recombinant Vaccines Products Offered
12.8.5 Novartis AG Recent Development
12.9 Bharat Biotech
12.9.1 Bharat Biotech Corporation Information
12.9.2 Bharat Biotech Description and Business Overview
12.9.3 Bharat Biotech Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bharat Biotech Recombinant Vaccines Products Offered
12.9.5 Bharat Biotech Recent Development
12.11 Merck & Co., Inc
12.11.1 Merck & Co., Inc Corporation Information
12.11.2 Merck & Co., Inc Description and Business Overview
12.11.3 Merck & Co., Inc Recombinant Vaccines Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck & Co., Inc Recombinant Vaccines Products Offered
12.11.5 Merck & Co., Inc Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Recombinant Vaccines Industry Trends
13.2 Recombinant Vaccines Market Drivers
13.3 Recombinant Vaccines Market Challenges
13.4 Recombinant Vaccines Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Recombinant Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Recombinant Vaccines Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Subunit Recombinant Vaccines
Table 3. Major Manufacturers of Attenuated Recombinant Vaccines
Table 4. Major Manufacturers of Vector Recombinant Vaccines
Table 5. Global Recombinant Vaccines Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 6. Global Recombinant Vaccines Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Recombinant Vaccines Sales by Regions (2016-2021) & (K Units)
Table 8. Global Recombinant Vaccines Sales Market Share by Regions (2016-2021)
Table 9. Global Recombinant Vaccines Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Recombinant Vaccines Sales Forecast by Region (2022-2027) & (K Units)
Table 11. Global Recombinant Vaccines Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Recombinant Vaccines Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Recombinant Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Recombinant Vaccines Sales by Manufacturers (2016-2021) (K Units)
Table 15. Global Recombinant Vaccines Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Recombinant Vaccines Manufacturers by Revenue (US$ Million) in 2020
Table 17. Recombinant Vaccines Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Recombinant Vaccines Revenue Share by Manufacturers (2016-2021)
Table 19. Global Recombinant Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Recombinant Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Vaccines as of 2020)
Table 21. Key Manufacturers Recombinant Vaccines Price (2016-2021) (USD/Unit)
Table 22. Recombinant Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Recombinant Vaccines Product Type
Table 24. Date of International Manufacturers Enter into Recombinant Vaccines Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Recombinant Vaccines Sales by Type (2016-2021) (K Units)
Table 27. Global Recombinant Vaccines Sales Share by Type (2016-2021)
Table 28. Global Recombinant Vaccines Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Recombinant Vaccines Revenue Share by Type (2016-2021)
Table 30. Recombinant Vaccines Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 31. Global Recombinant Vaccines Sales Forecast by Type (2022-2027) & (K Units)
Table 32. Global Recombinant Vaccines Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Recombinant Vaccines Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Recombinant Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Recombinant Vaccines Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 36. Global Recombinant Vaccines Sales by Application (2016-2021) (K Units)
Table 37. Global Recombinant Vaccines Sales Share by Application (2016-2021)
Table 38. Global Recombinant Vaccines Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Recombinant Vaccines Revenue Share by Application (2016-2021)
Table 40. Recombinant Vaccines Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 41. Global Recombinant Vaccines Sales Forecast by Application (2022-2027) & (K Units)
Table 42. Global Recombinant Vaccines Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Recombinant Vaccines Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Recombinant Vaccines Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Recombinant Vaccines Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 46. United States Recombinant Vaccines Sales (K Units) of Key Companies (2016-2021)
Table 47. United States Recombinant Vaccines Sales Share by Company (2016-2021)
Table 48. United States Recombinant Vaccines Revenue (US$ Million) by Company (2016-2021)
Table 49. United States Recombinant Vaccines Revenue Share by Company (2016-2021)
Table 50. United States Recombinant Vaccines Sales (K Units) by Type (2016-2021)
Table 51. United States Recombinant Vaccines Sales Share by Type (2016-2021)
Table 52. United States Recombinant Vaccines Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. United States Recombinant Vaccines Price (USD/Unit) by Type (2016-2021)
Table 54. United States Recombinant Vaccines Sales (K Units) by Type (2022-2027)
Table 55. United States Recombinant Vaccines Sales Share by Type (2022-2027)
Table 56. United States Recombinant Vaccines Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. United States Recombinant Vaccines Revenue Share by Type (2022-2027)
Table 58. United States Recombinant Vaccines Price (USD/Unit) by Type (2022-2027)
Table 59. United States Recombinant Vaccines Sales (K Units) by Application (2016-2021)
Table 60. United States Recombinant Vaccines Sales Share by Application (2016-2021)
Table 61. United States Recombinant Vaccines Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. United States Recombinant Vaccines Price (USD/Unit) by Application (2016-2021)
Table 63. United States Recombinant Vaccines Sales (K Units) by Application (2022-2027)
Table 64. United States Recombinant Vaccines Sales Share by Application (2022-2027)
Table 65. United States Recombinant Vaccines Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. United States Recombinant Vaccines Revenue Share by Application (2022-2027)
Table 67. United States Recombinant Vaccines Price (USD/Unit) by Application (2022-2027)
Table 68. North America Recombinant Vaccines Sales by Country (2016-2021) & (K Units)
Table 69. North America Recombinant Vaccines Sales Market Share by Country (2016-2021)
Table 70. North America Recombinant Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Recombinant Vaccines Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Recombinant Vaccines Sales by Region (2016-2021) & (K Units)
Table 73. Asia Pacific Recombinant Vaccines Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Recombinant Vaccines Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Recombinant Vaccines Revenue Market Share by Region (2016-2021)
Table 76. Europe Recombinant Vaccines Sales by Country (2016-2021) & (K Units)
Table 77. Europe Recombinant Vaccines Sales Market Share by Country (2016-2021)
Table 78. Europe Recombinant Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Recombinant Vaccines Revenue Market Share by Country (2016-2021)
Table 80. Latin America Recombinant Vaccines Sales by Country (2016-2021) & (K Units)
Table 81. Latin America Recombinant Vaccines Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Recombinant Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Recombinant Vaccines Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Recombinant Vaccines Sales by Country (2016-2021) & (K Units)
Table 85. Middle East and Africa Recombinant Vaccines Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Recombinant Vaccines Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Recombinant Vaccines Revenue Market Share by Country (2016-2021)
Table 88. Merck & Co., Inc Corporation Information
Table 89. Merck & Co., Inc Description and Business Overview
Table 90. Merck & Co., Inc Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Merck & Co., Inc Recombinant Vaccines Product
Table 92. Merck & Co., Inc Recent Development
Table 93. Green Cross Corporation Corporation Information
Table 94. Green Cross Corporation Description and Business Overview
Table 95. Green Cross Corporation Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Green Cross Corporation Product
Table 97. Green Cross Corporation Recent Development
Table 98. Pfizer Inc. Corporation Information
Table 99. Pfizer Inc. Description and Business Overview
Table 100. Pfizer Inc. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Pfizer Inc. Product
Table 102. Pfizer Inc. Recent Development
Table 103. Bayer AG Corporation Information
Table 104. Bayer AG Description and Business Overview
Table 105. Bayer AG Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Bayer AG Product
Table 107. Bayer AG Recent Development
Table 108. Sanofi S A. Corporation Information
Table 109. Sanofi S A. Description and Business Overview
Table 110. Sanofi S A. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Sanofi S A. Product
Table 112. Sanofi S A. Recent Development
Table 113. Protein Science Corporation Corporation Information
Table 114. Protein Science Corporation Description and Business Overview
Table 115. Protein Science Corporation Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Protein Science Corporation Product
Table 117. Protein Science Corporation Recent Development
Table 118. GlaxoSmithKline Plc. Corporation Information
Table 119. GlaxoSmithKline Plc. Description and Business Overview
Table 120. GlaxoSmithKline Plc. Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. GlaxoSmithKline Plc. Product
Table 122. GlaxoSmithKline Plc. Recent Development
Table 123. Novartis AG Corporation Information
Table 124. Novartis AG Description and Business Overview
Table 125. Novartis AG Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Novartis AG Product
Table 127. Novartis AG Recent Development
Table 128. Bharat Biotech Corporation Information
Table 129. Bharat Biotech Description and Business Overview
Table 130. Bharat Biotech Recombinant Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Bharat Biotech Product
Table 132. Bharat Biotech Recent Development
Table 133. Recombinant Vaccines Market Trends
Table 134. Recombinant Vaccines Market Drivers
Table 135. Recombinant Vaccines Market Challenges
Table 136. Recombinant Vaccines Market Restraints
Table 137. Recombinant Vaccines Customers List
Table 138. Recombinant Vaccines Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Vaccines Product Picture
Figure 2. Global Recombinant Vaccines Sales Market Share by Type in 2020 & 2027
Figure 3. Subunit Recombinant Vaccines Product Picture
Figure 4. Attenuated Recombinant Vaccines Product Picture
Figure 5. Vector Recombinant Vaccines Product Picture
Figure 6. Global Recombinant Vaccines Sales Market Share by Application in 2020 & 2027
Figure 7. Recombinant Human Vaccines
Figure 8. Animal Recombinant Vaccines
Figure 9. Recombinant Vaccines Report Years Considered
Figure 10. Global Recombinant Vaccines Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Recombinant Vaccines Market Size 2016-2027 (US$ Million)
Figure 12. Global Recombinant Vaccines Sales 2016-2027 (K Units)
Figure 13. Global Recombinant Vaccines Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Recombinant Vaccines Sales Market Share by Region (2016-2021)
Figure 15. Global Recombinant Vaccines Sales Market Share by Region in 2020
Figure 16. Global Recombinant Vaccines Revenue Market Share by Region (2016-2021)
Figure 17. Global Recombinant Vaccines Revenue Market Share by Region in 2020
Figure 18. Global Recombinant Vaccines Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Recombinant Vaccines Revenue in 2020
Figure 20. Recombinant Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Recombinant Vaccines Sales Market Share by Type (2016-2021)
Figure 22. Global Recombinant Vaccines Sales Market Share by Type in 2020
Figure 23. Global Recombinant Vaccines Revenue Market Share by Type (2016-2021)
Figure 24. Global Recombinant Vaccines Revenue Market Share by Type in 2020
Figure 25. Global Recombinant Vaccines Sales Market Share by Application (2016-2021)
Figure 26. Global Recombinant Vaccines Sales Market Share by Application in 2020
Figure 27. Global Recombinant Vaccines Revenue Market Share by Application (2016-2021)
Figure 28. Global Recombinant Vaccines Revenue Market Share by Application in 2020
Figure 29. United States Recombinant Vaccines Sales Growth Rate 2016-2027 (K Units)
Figure 30. United States Recombinant Vaccines Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States Recombinant Vaccines Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest Recombinant Vaccines Players Market Share by Revenue in Recombinant Vaccines in 2020
Figure 33. United States Recombinant Vaccines Revenue Share by Type (2016-2021)
Figure 34. United States Recombinant Vaccines Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States Recombinant Vaccines Revenue Share by Application (2016-2021)
Figure 36. United States Recombinant Vaccines Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Recombinant Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America Recombinant Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Recombinant Vaccines Sales Market Share by Country in 2020
Figure 40. North America Recombinant Vaccines Revenue Market Share by Country in 2020
Figure 41. U.S. Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Recombinant Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe Recombinant Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Recombinant Vaccines Sales Market Share by Country in 2020
Figure 48. Europe Recombinant Vaccines Revenue Market Share by Country in 2020
Figure 49. Germany Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 52. France Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Recombinant Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific Recombinant Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Recombinant Vaccines Sales Market Share by Region in 2020
Figure 62. Asia Pacific Recombinant Vaccines Revenue Market Share by Region in 2020
Figure 63. China Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 64. China Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 70. India Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 74. Taiwan Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 82. Philippines Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 84. Vietnam Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Recombinant Vaccines Sales Growth Rate 2016-2021 (K Units)
Figure 86. Latin America Recombinant Vaccines Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Recombinant Vaccines Sales Market Share by Country in 2020
Figure 88. Latin America Recombinant Vaccines Revenue Market Share by Country in 2020
Figure 89. Mexico Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 90. Mexico Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 92. Brazil Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Recombinant Vaccines Sales Growth Rate (2016-2021) (K Units)
Figure 94. Argentina Recombinant Vaccines Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Recombinant Vaccines Sales Growth Rate 2016-2021 (K Units

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs